Levi & korsinsky reminds alnylam investors of the ongoing investigation into potential violations of securities laws - alny

New york, ny / accesswire / april 17, 2024 / levi & korsinsky notifies investors that it has commenced an investigation of alnylam pharmaceuticals, inc. ("alnylam") (nasdaq:alny) concerning possible violations of federal securities laws. on september 13, 2023, alnylam announced the u.s. food and drug administration's (fda) cardiovascular and renal drugs advisory committee (crdac) approved alnylam's application to expand approval for onpattro to attr-cardiomyopathy (cm) patients.
ALNY Ratings Summary
ALNY Quant Ranking